Crystal structure at 180°K of bis-3,5- diisopropylsalicylatobisdimethylsulfoxidozinc(II) and the inhibition of seizures and polymorphonuclear leukocyte chemiluminescence

Journal of Inorganic Biochemistry

Volumn 70, Issue 2, 1998, Pages 137-143

  Morgant, Georges ^a,b   Viossat, Bernard ^c   Daran, Jean Claude ^d   Roch Arveiller, Monique ^e   Giroud, Jean Paul ^e   Dung, Nguyen Huy ^a   Sorenson, John R J ^f  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b ARMAND TROUSSEAU HOSPITAL   (France)

^c UNIVERSITÉ DE POITIERS   (France)

^d LCC LABORATOIRE DE CHIMIE DE COORDINATION   (France)

^e Hôpital Cochin ^*  (France)

^f UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BIS 3,5 DIISOPROPYLSALICYCATOBISDIMETHYLSULFOXIDOZINC; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; CRYSTAL STRUCTURE; DOWN REGULATION; DRUG CONFORMATION; ENZYME REGULATION; GRAND MAL EPILEPSY; MALE; MITOCHONDRIAL RESPIRATION; NEUTROPHIL; NONHUMAN; OXIDATION REDUCTION REACTION; PETIT MAL; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTICONVULSANTS; CHEMILUMINESCENT MEASUREMENTS; CRYSTALLOGRAPHY, X-RAY; DIMETHYL SULFOXIDE; ELECTROSHOCK; MALE; MICE; MICE, INBRED STRAINS; MODELS, MOLECULAR; NEUTROPHILS; ORGANOMETALLIC COMPOUNDS; PENTYLENETETRAZOLE; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY BURST; SEIZURES;

EID: 0031826086     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(98)10009-0     Document Type: Article

References (23)

1. Sorenson J.R.J., Soderberg L.S.F., Chang L.W., Willingham W.M., Baker M.L., Barnett J.B., Salari H., Bond K. European J. Med. Chem. 28:1993;221.
2. Sorenson J.R.J., Soderberg L.S.F., Chang L.W. Proced. Soc. Exptl. Biol. Med. 210:1995;191.
3. Greenaway F.T., Norris L.J., Sorenson J.R.J. Inorg. Chim. Acta. 145:1988;279.
4. Sorenson J.R.J. Prog. Med. Chem. 26:1989;437.
5. Altomare A., Cascarano G., Giacovazzo G., Guagliardi A., Burla M.C., Polidori G., Camalli M. J. Appl. Cryst. 27:1994;435.
6. E. Prince. Mathematical Techniques in Crystallography, Springer, Berlin, 1982.
7. D.J. Watkin, C.K Prout, J.R. Carruthers, P.W. Betteridge, CRYSTALS Issue 10, Chemical Crystallography Laboratory, University of Oxford, Oxford, 1996.
8. D.J. Watkin, C.K. Prout, L.J. Pearce, CAMERON, Chemical Crystallography Laboratory, University of Oxford, Oxford, 1996.
9. International Tables for X-ray Crystallography, Kynock Press, Birmingham, England, vol IV, 1974, p. 99.
10. Roch-Arveiller M., Relevant V., Pham Huy D., Maman L., Fontagne J., Sorenson J.R.J., Giroud J.P. Agents and Actions. 31:1990;65.
11. Klug H.P., Alexander L.E., Summer G.G. Acta Crystallogr. 11:1958;41.
12. van de Giesen W., Stam C.H. Cryts. Struct. Comm. 1:1972;257.
13. Yar O., Lessinger L. Acta Crystallogr. C. 51:1995;2282.
14. Capilla A.V., Aranda R.A. Cryts. Struct. Comm. 8:1979;795.
15. van Niekerk J.N., Schoening F.R.L., Talbot J.H. Acta Crystallogr. 6:1953;720.
16. Koyama H., Saito Y. Bull. J. Chem. Soc. Jpn. 27:1954;112.
17. J.D. Ranford, P.J. Sadler, D.A Tocher, J. Chem. Soc. Dalton Trans. 3393 (1993).
18. Gay J.C., Lukens J.N., English D.K. Inflammation. 8:1984;209.
19. Kaim W., Rall J. Angew. Chem. Int. Ed. Engl. 35:1996;43.
20. Forbes I.J., Zalewski P.D., Giannakis C. Exp. Cell. Res. 195:1991;224.
21. Singla A.K., Medittara D.K., Pathak K. Int. J. Pharmaceut. 60:1990;27.
22. Williamson A., Spencer D. Neuroreport. 6:1995;1562.
23. Mayer B., Pfeiffer S., Leopold E., Müller J., Weser U., Schmidt K. Neurosci. Lett. 209:1996;169.